However, the blockade of IL-6–mediated signaling by a neutralizing anti–IL-6 Ab strongly inhibited CD28-induced IL-22 gene expression (Figure 1H) and secretion (Figure 1I) in CD4+ T cells from HD. This evidence concerns the gene IL22 and Huntington disease.